REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

VICTORY CAPITAL MANAGEMENT INC's Holding History (CIK: 0001040188)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 11,788 Value ($000) $36 Avg Close Range
Q3 2024
Shares 12,073 Value ($000) $63 Avg Close Range
Q2 2024
Shares 12,309 Value ($000) $32 Avg Close Range
Q1 2024
Shares 10,401 Value ($000) $51 Avg Close Range
Q4 2023
Shares 10,554 Value ($000) $93 Avg Close Range
Q2 2023
Shares 564,355 Value ($000) $14,284 Avg Close Range
Q1 2023
Shares 598,685 Value ($000) $19,284 Avg Close Range
Q4 2022
Shares 31,130 Value ($000) $575 Avg Close Range
Q3 2022
Shares 40,540 Value ($000) $1,094 Avg Close Range
Q3 2021
Shares 9,482 Value ($000) $264 Avg Close Range
Q2 2021
Shares 9,918 Value ($000) $294 Avg Close Range
Q1 2021
Shares 10,202 Value ($000) $285 Avg Close Range
Q4 2020
Shares 9,811 Value ($000) $278 Avg Close Range
Q3 2020
Shares 9,328 Value ($000) $235 Avg Close Range
Q1 2020
Shares 7,983 Value ($000) $118 Avg Close Range
Q4 2019
Shares 9,847 Value ($000) $160 Avg Close Range
Q3 2019
Shares 6,339 Value ($000) $82 Avg Close Range
Q2 2018
Shares 59,245 Value ($000) $1,626 Avg Close Range
Q1 2018
Shares 62,545 Value ($000) $1,926 Avg Close Range
Q4 2017
Shares 55,685 Value ($000) $1,991 Avg Close Range
Q3 2017
Shares 34,715 Value ($000) $956 Avg Close Range
Q2 2017
Shares 34,875 Value ($000) $921 Avg Close Range
Q1 2017
Shares 35,525 Value ($000) $739 Avg Close Range